42 related articles for article (PubMed ID: 27908834)
1. Gamma secretase inhibitor impairs epithelial-to-mesenchymal transition induced by TGF-β in ovarian tumor cell lines.
Pazos MC; Abramovich D; Bechis A; Accialini P; Parborell F; Tesone M; Irusta G
Mol Cell Endocrinol; 2017 Jan; 440():125-137. PubMed ID: 27908834
[TBL] [Abstract][Full Text] [Related]
2. Epithelial mesenchymal transition and pancreatic tumor initiating CD44+/EpCAM+ cells are inhibited by γ-secretase inhibitor IX.
Palagani V; El Khatib M; Kossatz U; Bozko P; Müller MR; Manns MP; Krech T; Malek NP; Plentz RR
PLoS One; 2012; 7(10):e46514. PubMed ID: 23094026
[TBL] [Abstract][Full Text] [Related]
3. The expression of presenilin 1 enhances carcinogenesis and metastasis in gastric cancer.
Li P; Lin X; Zhang JR; Li Y; Lu J; Huang FC; Zheng CH; Xie JW; Wang JB; Huang CM
Oncotarget; 2016 Mar; 7(9):10650-62. PubMed ID: 26872378
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of γ-secretase/Notch pathway as a potential therapy for reversing cancer drug resistance.
Feng M; Santhanam RK; Xing H; Zhou M; Jia H
Biochem Pharmacol; 2024 Feb; 220():115991. PubMed ID: 38135129
[TBL] [Abstract][Full Text] [Related]
5. Confocal Raman Spectral Imaging Study of DAPT, a γ-secretase Inhibitor, Induced Physiological and Biochemical Reponses in Osteosarcoma Cells.
Li J; Wang R; Qin J; Zeng H; Wang K; He Q; Wang D; Wang S
Int J Med Sci; 2020; 17(5):577-590. PubMed ID: 32210707
[TBL] [Abstract][Full Text] [Related]
6. Roles of GSK-3 and microRNAs on epithelial mesenchymal transition and cancer stem cells.
McCubrey JA; Fitzgerald TL; Yang LV; Lertpiriyapong K; Steelman LS; Abrams SL; Montalto G; Cervello M; Neri LM; Cocco L; Martelli AM; Laidler P; Dulińska-Litewka J; Rakus D; Gizak A; Nicoletti F; Falzone L; Candido S; Libra M
Oncotarget; 2017 Feb; 8(8):14221-14250. PubMed ID: 27999207
[TBL] [Abstract][Full Text] [Related]
7. Elevation of YAP promotes the epithelial-mesenchymal transition and tumor aggressiveness in colorectal cancer.
Ling HH; Kuo CC; Lin BX; Huang YH; Lin CW
Exp Cell Res; 2017 Jan; 350(1):218-225. PubMed ID: 27914787
[TBL] [Abstract][Full Text] [Related]
8. Diverse pathways of epithelial mesenchymal transition related with cancer progression and metastasis and potential effects of endocrine disrupting chemicals on epithelial mesenchymal transition process.
Lee HM; Hwang KA; Choi KC
Mol Cell Endocrinol; 2017 Dec; 457():103-113. PubMed ID: 28042023
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia induced Bcl-2/Twist1 complex promotes tumor cell invasion in oral squamous cell carcinoma.
Duan Y; He Q; Yue K; Si H; Wang J; Zhou X; Wang X
Oncotarget; 2017 Jan; 8(5):7729-7739. PubMed ID: 28032603
[TBL] [Abstract][Full Text] [Related]
10. Pellino-1 promotes lung carcinogenesis via the stabilization of Slug and Snail through K63-mediated polyubiquitination.
Jeon YK; Kim CK; Hwang KR; Park HY; Koh J; Chung DH; Lee CW; Ha GH
Cell Death Differ; 2017 Mar; 24(3):469-480. PubMed ID: 28009353
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneity and plasticity of epithelial-mesenchymal transition (EMT) in cancer metastasis: Focusing on partial EMT and regulatory mechanisms.
Li D; Xia L; Huang P; Wang Z; Guo Q; Huang C; Leng W; Qin S
Cell Prolif; 2023 Jun; 56(6):e13423. PubMed ID: 36808651
[TBL] [Abstract][Full Text] [Related]
12. The Role of Cytokines in Epithelial-Mesenchymal Transition in Gynaecological Cancers: A Systematic Review.
Ray I; Michael A; Meira LB; Ellis PE
Cells; 2023 Jan; 12(3):. PubMed ID: 36766756
[TBL] [Abstract][Full Text] [Related]
13. Notch signaling in female cancers: a multifaceted node to overcome drug resistance.
Giuli MV; Mancusi A; Giuliani E; Screpanti I; Checquolo S
Cancer Drug Resist; 2021; 4(4):805-836. PubMed ID: 35582386
[TBL] [Abstract][Full Text] [Related]
14. Numb-PRRL promotes TGF-β1- and EGF-induced epithelial-to-mesenchymal transition in pancreatic cancer.
Sheng W; Tang J; Cao R; Shi X; Ma Y; Dong M
Cell Death Dis; 2022 Feb; 13(2):173. PubMed ID: 35197444
[TBL] [Abstract][Full Text] [Related]
15. Activation of Pancreatic Stellate Cells Is Beneficial for Exocrine but Not Endocrine Cell Differentiation in the Developing Human Pancreas.
Li J; Chen B; Fellows GF; Goodyer CG; Wang R
Front Cell Dev Biol; 2021; 9():694276. PubMed ID: 34490247
[TBL] [Abstract][Full Text] [Related]
16. Concomitant attenuation of HMGCR expression and activity enhances the growth inhibitory effect of atorvastatin on TGF-β-treated epithelial cancer cells.
Warita K; Ishikawa T; Sugiura A; Tashiro J; Shimakura H; Hosaka YZ; Ohta KI; Warita T; Oltvai ZN
Sci Rep; 2021 Jun; 11(1):12763. PubMed ID: 34140545
[TBL] [Abstract][Full Text] [Related]
17. Gamma Secretase Inhibitors in Cancer: A Current Perspective on Clinical Performance.
McCaw TR; Inga E; Chen H; Jaskula-Sztul R; Dudeja V; Bibb JA; Ren B; Rose JB
Oncologist; 2021 Apr; 26(4):e608-e621. PubMed ID: 33284507
[TBL] [Abstract][Full Text] [Related]
18. Osteosarcoma cells induce differentiation of mesenchymal stem cells into cancer associated fibroblasts through Notch and Akt signaling pathway.
Wang YM; Wang W; Qiu ED
Int J Clin Exp Pathol; 2017; 10(8):8479-8486. PubMed ID: 31966700
[TBL] [Abstract][Full Text] [Related]
19. Regulation of Proliferation and Epithelial-to-Mesenchymal Transition (EMT) of Gastric Cancer by ZEB1 via Modulating Wnt5a and Related Mechanisms.
Xue Y; Zhang L; Zhu Y; Ke X; Wang Q; Min H
Med Sci Monit; 2019 Mar; 25():1663-1670. PubMed ID: 30829316
[TBL] [Abstract][Full Text] [Related]
20. Gremlin Regulates Tubular Epithelial to Mesenchymal Transition via VEGFR2: Potential Role in Renal Fibrosis.
Marquez-Exposito L; Lavoz C; Rodrigues-Diez RR; Rayego-Mateos S; Orejudo M; Cantero-Navarro E; Ortiz A; Egido J; Selgas R; Mezzano S; Ruiz-Ortega M
Front Pharmacol; 2018; 9():1195. PubMed ID: 30386246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
